Centene Corp. buy stratec
Start price
28.04.20
/
50%
€63.00
Target price
04.11.21
€75.00
Performance (%)
2.38%
End price
05.11.21
€64.50
Summary
This prediction ended on 05.11.21 with a price of €64.50. With a performance of 2.38%, the BUY prediction by stratec for Centene Corp. closed with a slight gain. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Centene Corp. | -3.274% | -3.274% | -44.174% | -48.266% |
| iShares Core DAX® | -0.437% | -5.315% | 1.438% | 57.846% |
| iShares Nasdaq 100 | -0.194% | 3.078% | 18.683% | 84.823% |
| iShares Nikkei 225® | -0.951% | -5.884% | 27.860% | 54.805% |
| iShares S&P 500 | -0.420% | 0.922% | 13.173% | 64.029% |
Comments by stratec for this prediction
In the thread Centene Corp. diskutieren
Centene Corporation - A Growth Company Perfect For A Value Investor
CNC is growing at a rapid rate and only has a Forward P/E of 10.88. The potential investment in the company is for a growth and value investor.
Revenues: $26,025M (+41.1%); Medicaid: $17,041M (+35.2%); Commercial: $4,119M (+13.0%); Medicare: $3,016M (+118.2%); Medicare PDP: $600M; Other: $1,249M (+54.4%).
Revenues: $26,025M (+41.1%); Medicaid: $17,041M (+35.2%); Commercial: $4,119M (+13.0%); Medicare: $3,016M (+118.2%); Medicare PDP: $600M; Other: $1,249M (+54.4%).
In the thread Trading Centene Corp.
Die von stratec gewählte maximale Laufzeit wurde überschritten